The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years. uri icon

authors

  • Brown, Darron R
  • Patricia Garcia, Psy.D., HSPP
  • Ault, Kevin A
  • Garland, Suzanne M
  • Leodolter, Sepp
  • Olsson, Sven-Eric
  • Tang, Grace W K
  • Ferris, Daron G
  • Paavonen, Jorma
  • Steben, Marc
  • Bosch, F Xavier
  • Kjaer, Susanne K
  • Dillner, Joakim
  • Joura, Elmar A
  • Kurman, Robert J
  • Majewski, Slawomir
  • Muñoz, Nubia
  • Myers, Evan R
  • Villa, Luisa L
  • Taddeo, Frank J
  • Roberts, Christine
  • Tadesse, Amha
  • Sigurdsson, Kristján
  • Bryan, Janine
  • Lupinacci, Lisa C
  • Giacoletti, Katherine E D
  • Sings, Heather L
  • James, Margaret
  • Hesley, Teresa M
  • Barr, Eliav
  • Iversen, Ole-Erik
  • Hernandez-Avila, Mauricio
  • Wheeler, Cosette M
  • Perez, Gonzalo
  • Koutsky, Laura A
  • Tay, Eng Hseon

publication date

  • April 1, 2009